Nonenzymatic kinetic resolution of racemic β-hydroxyalkanephosphonates with a chiral copper catalyst

DOI: 10.1016/j.tetasy.2010.04.059

Source and publish data:

Tetrahedron Asymmetry p. 810 - 824 (2010)

Update date:2022-08-03

Topics:

Authors:

Moriyama, Atsushi

Matsumura, Shintaro

Kuriyama, Masami

Onomura, Osamu

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1016/j.tetasy.2010.04.059

Kinetic resolution of β-hydroxyalkanephosphonates was efficiently performed by 2-fluorobenzoylation in the presence of copper(II) triflate and (R,R)-Ph-BOX as a catalyst with good s value of up to 21.

Full text of DOI:10.1016/j.tetasy.2010.04.059

Products guided by the article

Product name:dimethyl (R)-(2-phenyl-2-phenylaminocarbonyloxyethyl)phosphonate

Cas No:1239972-03-2

R&D Labs maybe for 1239972-03-2

Taizhou Elitechemie MediPharma Technology Co.,Ltd.

Contact:+86-523-86810021

Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Hebei Think-Do Environment Co., Ltd

website:http://www.thinkdo-environment.com

Contact:0311-86510809-

Address:No 6, Shilian Middle Street, Circular Chemical Industry Park
Hangzhou Showland Technology Co., Ltd.

Contact:86-571-88920516

Address:ROOM2118,NO.553,WENSAN ROAD,HANGZHOU,CHINA
Deltachem(QingDao)Co.,Ltd.

Contact:+8618766299236

Address:ROOM808, BUILDING2,NO.230 SHEN ZHEN ROAD, LAOSHAN DISTRICT
EnBridge PharmTech Co., Ltd.

website:http://www.enbridgepharm.com

Contact:+86-510-83591909

Address:Huishan Zone, Wuxi City, Jiangsu Province, P.R.China

Relevant to this article

Arylation of pyridines via suzuki-miyaura cross-coupling and pyridine-directed C-H activation using a continuous-flow approach

Doi:10.1055/s-0033-1339870
(2013)
Halogen migration vs. hydrogen halogenide elimination in reactions of 1-chloro-2,2,2-trifluoroethansulfonyl chloride and 1,2,2,2-tetrafluoroethansulfonyl fluoride with amines: theoretical and experimental investigation

Doi:10.1016/j.jfluchem.2009.11.001
(2010)
Discovery and optimization of a novel series of GPR142 agonists for the treatment of type 2 diabetes mellitus

Doi:10.1016/j.bmcl.2012.07.063
(2012)
Doi:10.1002/hlca.193601901175
(1936)
New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy

Doi:10.1002/jps.22121
(2010)
Highly diastereo-and enantioselective synthesis of monodifferentiated syn-1,2-diol derivatives through asymmetric transfer hydrogenation via dynamic kinetic resolution

Doi:10.1021/ol101451s
(2010)

Article Doi